Adverse effect of botulinum toxin-A injections on mandibular bone: A systematic review and meta-analysis.
Abstract
[INTRODUCTION] Botulinum toxin-A (BTX) is a potent neurotoxin that is emerging in the scope of dental practice for its ability to temporarily paralyse musculature and reduce hyperfunction. This may be desirable in diseases/disorders associated with hyperactive muscles such as the muscles of mastication, most implicated in painful temporomandibular disorders (TMDs). The use of BTX extends beyond its indications with off-label use in TMD's and other conditions, while potential adverse effects remain understudied. BTX is well-established hindlimb paralysis model in animals leading to significant bone loss with underlying mechanisms remaining unclear. The objective of this study is to systematically review the literature for articles investigating changes in mandibular bone following BTX injections and meta-analyse available data on reported bone outcomes.
[METHODS] Comprehensive search of Medline, Embase and Web of Science retrieved 934 articles. Following the screening process, 36 articles in animals and humans were included for quantitative synthesis. Articles in human individuals (6) and three different animal species (14) presented mandibular bone outcomes that were included in the meta-analysis.
[RESULTS] The masseter and temporalis muscles were frequently injected across all species. In humans, we observe a decrease of about 6% in cortical thickness of mandibular regions following BTX injection with no evident changes in either volume or density of bone structures. In animals, bone loss in the condylar region is significantly high in both cortical and trabecular compartments.
[DISCUSSION] Our analysis supports the concept of BTX-induced bone-loss model in animal mandibles. Further, bone loss might be confined to the cortical compartments in humans. Most studies did not address the reality of repeated injections and excessive dosing, which occur due to the reversible action of BTX. More rigorous trials are needed to draw a full picture of potential long-term adverse effects on bone.
[METHODS] Comprehensive search of Medline, Embase and Web of Science retrieved 934 articles. Following the screening process, 36 articles in animals and humans were included for quantitative synthesis. Articles in human individuals (6) and three different animal species (14) presented mandibular bone outcomes that were included in the meta-analysis.
[RESULTS] The masseter and temporalis muscles were frequently injected across all species. In humans, we observe a decrease of about 6% in cortical thickness of mandibular regions following BTX injection with no evident changes in either volume or density of bone structures. In animals, bone loss in the condylar region is significantly high in both cortical and trabecular compartments.
[DISCUSSION] Our analysis supports the concept of BTX-induced bone-loss model in animal mandibles. Further, bone loss might be confined to the cortical compartments in humans. Most studies did not address the reality of repeated injections and excessive dosing, which occur due to the reversible action of BTX. More rigorous trials are needed to draw a full picture of potential long-term adverse effects on bone.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | mandibular bone
|
scispacy | 1 | ||
| 해부 | musculature
|
scispacy | 1 | ||
| 해부 | muscles
|
scispacy | 1 | ||
| 해부 | TMD
|
scispacy | 1 | ||
| 해부 | hindlimb
|
scispacy | 1 | ||
| 해부 | bone
|
scispacy | 1 | ||
| 해부 | masseter
|
scispacy | 1 | ||
| 해부 | temporalis muscles
|
scispacy | 1 | ||
| 해부 | cortical
|
scispacy | 1 | ||
| 해부 | condylar
|
scispacy | 1 | ||
| 해부 | trabecular
|
scispacy | 1 | ||
| 합병증 | mandibular bone
|
scispacy | 1 | ||
| 합병증 | mandibular regions
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION] Botulinum toxin-A
|
scispacy | 1 | ||
| 약물 | BTX
→ Botulinum toxin-A
|
scispacy | 1 | ||
| 질환 | hyperactive
|
C0424295
Hyperactive behavior
|
scispacy | 1 | |
| 질환 | temporomandibular disorders
|
C0039494
Temporomandibular Joint Disorders
|
scispacy | 1 | |
| 질환 | TMDs
→ temporomandibular disorders
|
C0039494
Temporomandibular Joint Disorders
|
scispacy | 1 | |
| 질환 | paralysis
|
C0522224
Paralysed
|
scispacy | 1 | |
| 질환 | bone loss
|
C0029453
Osteopenia
|
scispacy | 1 | |
| 질환 | bone-loss
|
scispacy | 1 | ||
| 질환 | BTX
→ Botulinum toxin-A
|
scispacy | 1 | ||
| 기타 | botulinum toxin-A
|
scispacy | 1 | ||
| 기타 | neurotoxin
|
scispacy | 1 | ||
| 기타 | BTX
→ Botulinum toxin-A
|
scispacy | 1 | ||
| 기타 | humans
|
scispacy | 1 | ||
| 기타 | human individuals (6)
|
scispacy | 1 | ||
| 기타 | cortical
|
scispacy | 1 |
MeSH Terms
Animals; Humans; Botulinum Toxins, Type A; Mandible; Masseter Muscle; Muscles; Injections, Intramuscular
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.